Blood pressure in early autosomal dominant polycystic kidney disease (Q35129320)

6 August 2017

Blood pressure in early autosomal dominant polycystic kidney disease (English)

1 reference

autosomal dominant polycystic kidney disease

6 August 2017

0 references

autosomal dominant polycystic kidney

1 reference

inferred from title

author

Robert William Schrier

1

object named as

Robert W Schrier

1 reference

6 August 2017

11

Dana C Miskulin

1 reference

6 August 2017

Kaleab Z Abebe

2

1 reference

6 August 2017

Ronald D Perrone

3

1 reference

6 August 2017

Vicente E Torres

4

1 reference

6 August 2017

William E Braun

5

1 reference

6 August 2017

Theodore I Steinman

6

1 reference

6 August 2017

Franz T Winklhofer

7

1 reference

6 August 2017

Godela Brosnahan

8

1 reference

6 August 2017

Peter G Czarnecki

9

1 reference

6 August 2017

Marie C Hogan

10

1 reference

6 August 2017

Frederic F Rahbari-Oskoui

12

1 reference

6 August 2017

Jared J Grantham

13

1 reference

6 August 2017

Peter C Harris

14

1 reference

6 August 2017

Michael F Flessner

15

1 reference

6 August 2017

Kyongtae T Bae

16

1 reference

6 August 2017

Charity G Moore

17

1 reference

6 August 2017

Arlene B Chapman

18

1 reference

6 August 2017

HALT-PKD Trial Investigators

19

1 reference

6 August 2017

language of work or name

English

0 references

publication date

15 November 2014

1 reference

The New England Journal of Medicine

6 August 2017

1 reference

6 August 2017

371

1 reference

6 August 2017

24

1 reference

6 August 2017

2255-2266

1 reference

Predictors of autosomal dominant polycystic kidney disease progression

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4343258

Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4343258

Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4343258

Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4343258

Analysis of baseline parameters in the HALT polycystic kidney disease trials.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4343258

Use of antihypertensive medications and mortality of patients with autosomal dominant polycystic kidney disease: a population-based study

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4343258

Improved prognosis in patients with autosomal dominant polycystic kidney disease in Denmark

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4343258

The HALT polycystic kidney disease trials: design and implementation

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4343258

Aldosterone as a renal growth factor

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4343258

Autosomal dominant polycystic kidney disease: the last 3 years

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4343258

MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4343258

Clinical practice. Autosomal dominant polycystic kidney disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4343258

Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4343258

Angiotensin II activation of cyclin D1-dependent kinase activity

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4343258

Random-effects models for longitudinal data

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4343258

The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4343258

Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4343258

Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4343258

Epidemiology, outcomes and validation of RIFLE and AKIN criteria in acute kidney injury (AKI) in critically ill patients: Indian perspective

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4343258

Changes in causes of death and risk of cancer in Danish patients with autosomal dominant polycystic kidney disease and end-stage renal disease

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4343258

Chronic treatment with lisinopril decreases proliferative and apoptotic pathways in autosomal recessive polycystic kidney disease

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4343258

Effect of statin and angiotensin-converting enzyme inhibition on structural and hemodynamic alterations in autosomal dominant polycystic kidney disease model.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4343258

Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4343258

Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease

27 September 2018

1 reference

12 December 2020

The anatomy of the renin-secreting cell in adult polycystic kidney disease

1 reference

12 December 2020

Hypertension and autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Renal structure and hypertension in autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease

1 reference

12 December 2020

Effect of sodium chloride, enalapril, and losartan on the development of polycystic kidney disease in Han:SPRD rats

1 reference

12 December 2020

Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group

1 reference

12 December 2020

Volume progression in polycystic kidney disease

1 reference

12 December 2020

Identifiers

DOI

10.1056/NEJMOA1402685

1 reference

6 August 2017

1 reference

6 August 2017

1 reference